FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
PloS one2015; 10(4); e0122954; doi: 10.1371/journal.pone.0122954

Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.

Abstract: Multipotent mesenchymal stromal cells (MSC) have attracted interest for their cytotherapeutic potential, partly due to their immunomodulatory abilities. The aim of this study was to test the robustness of our equine cord blood (CB) MSC isolation protocol, to characterize the CB-MSC before and after cryopreservation, and to evaluate their immunosuppressive phenotype. We hypothesized that MSC can be consistently isolated from equine CB, have unique and reproducible marker expression and in vitro suppress lymphoproliferation. Preliminary investigation of constitutive cytoplasmic Toll-like receptor (TLR) 3 and 4 expression was also preformed due to their possible association with anti- or pro-inflammatory MSC phenotypes, respectively. Surface markers were assessed for antigen and mRNA expression by flow cytometry and quantitative polymerase chain reaction (qPCR). Immunomodulatory properties were evaluated in mixed lymphocyte reaction assays, and TLR3 and TLR4 expression were measured by qPCR and immunocytochemistry (ICC). CB-MSC were isolated from each off nine cord blood samples. CB-MSC highly expressed CD29, CD44, CD90, and lacked or had low expression of major histocompatibility complex (MHC) class I, MHC-II, CD4, CD8, CD11a/18 and CD73 before and after cryopreservation. CB-MSC suppressed in vitro lymphoproliferation and constitutively expressed TLR4. Our findings confirmed CB as a reliable MSC source, provides an association of surface marker phenotype and mRNA expression and suggest anti-inflammatory properties of CB-MSC. The relationship between TLRs and lymphocyte function warrants further investigation.
Get Full Text
Publication Date: 2015-04-22 PubMed ID: 25902064PubMed Central: PMC4406608DOI: 10.1371/journal.pone.0122954Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explores the potential of mesenchymal stromal cells (MSC) derived from equine cord blood for immune suppression and healing applications. The study also delves into the stability of these cells after cryopreservation and their characteristic features.

Objective and Hypothesis

  • The main goal of this research was to investigate the effectiveness of the existing protocol for isolating MSC from equine cord blood and to further study the behavior and features of these cells both before and after cryopreservation.
  • The researchers hypothesized that MSC could be reliably obtained from equine cord blood, and that these cells would have a unique and reproducible marker expression. They also expected that, under in vitro conditions, these cells would inhibit the proliferation of lymphocytes.

Experiments and Methods Used

  • The study included an initial exploration of Toll-like receptors (TLR) 3 and 4, as there could be a potential relationship between these receptors and the anti-inflammatory or pro-inflammatory phenotypes of MSC.
  • Surface markers on the MSC were studied both in terms of antigen and mRNA expression using flow cytometry and quantitative polymerase chain reaction (qPCR) methods.
  • The researchers also performed mixed lymphocyte reaction assays to better understand the immunomodulatory properties of these cells.
  • The levels of expression of TLR3 and TLR4 were assessed using qPCR and immunocytochemistry (ICC).

Results

  • The researchers successfully isolated CB-MSC from each of the nine samples of cord blood used in the study.
  • The CB-MSC expressed high levels of CD29, CD44, and CD90 markers, and either lacked or expressed very low levels of other markers such as MHC class I, MHC-II, CD4, CD8, CD11a/18 and CD73 both before and after cryopreservation.
  • CB-MSC demonstrated the ability to suppress the proliferation of lymphocytes under in vitro conditions and consistently expressed TLR4.

Conclusion

  • The study findings affirmed the viability of cord blood as a dependable source for MSC and displayed a correlation of surface marker phenotype with mRNA expression.
  • The study suggests that the CB-MSC possess anti-inflammatory properties.
  • Further investigations are recommended to elaborate on the connections between TLRs and lymphocyte function.

Cite This Article

APA
Tessier L, Bienzle D, Williams LB, Koch TG. (2015). Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells. PLoS One, 10(4), e0122954. https://doi.org/10.1371/journal.pone.0122954

Publication

PloS one
ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 10
Issue: 4
Pages: e0122954
PII: e0122954

Researcher Affiliations

Tessier, Laurence
  • Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada.
Bienzle, Dorothee
  • Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada.
Williams, Lynn B
  • Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Canada.
Koch, Thomas G
  • Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada; The Orthopaedic Research Lab, Aarhus University, Aarhus, Denmark.

MeSH Terms

  • Animals
  • Antigens, CD / metabolism
  • Biomarkers / blood
  • Cell Proliferation
  • Cell Separation
  • Cryopreservation
  • Fetal Blood / cytology
  • Gene Expression Regulation
  • Horses
  • Humans
  • Immunomodulation
  • Leukocytes / cytology
  • Lymphocytes / cytology
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / immunology
  • Phenotype
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Toll-Like Receptor 3 / genetics
  • Toll-Like Receptor 4 / genetics

Conflict of Interest Statement

T. G. Koch acts in a volunteer capacity as non-executive Director, Scientific Affairs (ex officio) of eQcell therapies Inc., Aurora, Ontario, Canada, a company for which T. G. Koch’s research laboratory provides equine stem cell isolation and storage services. T. G. Koch holds a minor non-controlling share in eQcell therapies Inc. L. Tessier, D. Bienzle and L. B. Williams declare no competing interests. The authors hereby confirm that this does not alter their adherence to all PLOS ONE policies on sharing data and materials, as detailed online in your guide for authors http://www.PLOSone.org/static/editorial.action#competing. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

References

This article includes 63 references
  1. Cyranoski D. Stem cells boom in vet clinics.. Nature 2013 Apr 11;496(7444):148-9.
    doi: 10.1038/496148apubmed: 23579655google scholar: lookup
  2. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis.. J Orthop Res 2009 Dec;27(12):1675-80.
    doi: 10.1002/jor.20933pubmed: 19544397google scholar: lookup
  3. Frisbie DD. Future directions in treatment of joint disease in horses.. Vet Clin North Am Equine Pract 2005 Dec;21(3):713-24, viii.
    doi: 10.1016/j.cveq.2005.07.001pubmed: 16297729google scholar: lookup
  4. Koch TG, Berg LC, Betts DH. Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.. Can Vet J 2009 Feb;50(2):155-65.
    pmc: PMC2629419pubmed: 19412395
  5. Koch TG, Berg LC, Betts DH. Concepts for the clinical use of stem cells in equine medicine.. Can Vet J 2008 Oct;49(10):1009-17.
    pmc: PMC2553494pubmed: 19119371
  6. Fortier LA, Travis AJ. Stem cells in veterinary medicine.. Stem Cell Res Ther 2011 Feb 23;2(1):9.
    doi: 10.1186/scrt50pmc: PMC3092149pubmed: 21371354google scholar: lookup
  7. Chagastelles PC, Nardi NB. Biology of stem cells: an overview.. Kidney Int Suppl (2011) 2011 Sep;1(3):63-67.
    doi: 10.1038/kisup.2011.15pmc: PMC4089750pubmed: 25028627google scholar: lookup
  8. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    doi: 10.1080/14653240600855905pubmed: 16923606google scholar: lookup
  9. Paebst F, Piehler D, Brehm W, Heller S, Schroeck C, Tárnok A, Burk J. Comparative immunophenotyping of equine multipotent mesenchymal stromal cells: an approach toward a standardized definition.. Cytometry A 2014 Aug;85(8):678-87.
    doi: 10.1002/cyto.a.22491pubmed: 24894974google scholar: lookup
  10. Kang JG, Park SB, Seo MS, Kim HS, Chae JS, Kang KS. Characterization and clinical application of mesenchymal stem cells from equine umbilical cord blood.. J Vet Sci 2013;14(3):367-71.
    pmc: PMC3788164pubmed: 23820166doi: 10.4142/jvs.2013.14.3.367google scholar: lookup
  11. Mohanty N, Gulati BR, Kumar R, Gera S, Kumar P, Somasundaram RK, Kumar S. Immunophenotypic characterization and tenogenic differentiation of mesenchymal stromal cells isolated from equine umbilical cord blood.. In Vitro Cell Dev Biol Anim 2014 Jun;50(6):538-48.
    doi: 10.1007/s11626-013-9729-7pubmed: 24414976google scholar: lookup
  12. De Schauwer C, Goossens K, Piepers S, Hoogewijs MK, Govaere JL, Smits K, Meyer E, Van Soom A, Van de Walle GR. Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources.. Stem Cell Res Ther 2014 Jan 13;5(1):6.
    doi: 10.1186/scrt395pmc: PMC4055120pubmed: 24418262google scholar: lookup
  13. Radtke CL, Nino-Fong R, Esparza Gonzalez BP, Stryhn H, McD￮ LA. Characterization and osteogenic potential of equine muscle tissue- and periosteal tissue-derived mesenchymal stem cells in comparison with bone marrow- and adipose tissue-derived mesenchymal stem cells.. Am J Vet Res 2013 May;74(5):790-800.
    doi: 10.2460/ajvr.74.5.790pubmed: 23627394google scholar: lookup
  14. Ranera B, Ordovás L, Lyahyai J, Bernal ML, Fernandes F, Remacha AR, Romero A, Vázquez FJ, Osta R, Cons C, Varona L, Zaragoza P, Martín-Burriel I, Rodellar C. Comparative study of equine bone marrow and adipose tissue-derived mesenchymal stromal cells.. Equine Vet J 2012 Jan;44(1):33-42.
    doi: 10.1111/j.2042-3306.2010.00353.xpubmed: 21668489google scholar: lookup
  15. Ranera B, Lyahyai J, Romero A, Vázquez FJ, Remacha AR, Bernal ML, Zaragoza P, Rodellar C, Martín-Burriel I. Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue.. Vet Immunol Immunopathol 2011 Nov 15;144(1-2):147-54.
    doi: 10.1016/j.vetimm.2011.06.033pubmed: 21782255google scholar: lookup
  16. De Schauwer C, Piepers S, Van de Walle GR, Demeyere K, Hoogewijs MK, Govaere JL, Braeckmans K, Van Soom A, Meyer E. In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry.. Cytometry A 2012 Apr;81(4):312-23.
    doi: 10.1002/cyto.a.22026pubmed: 22411893google scholar: lookup
  17. Braun J, Hack A, Weis-Klemm M, Conrad S, Treml S, Kohler K, Walliser U, Skutella T, Aicher WK. Evaluation of the osteogenic and chondrogenic differentiation capacities of equine adipose tissue-derived mesenchymal stem cells.. Am J Vet Res 2010 Oct;71(10):1228-36.
    doi: 10.2460/ajvr.71.10.1228pubmed: 20919912google scholar: lookup
  18. Lovati AB, Corradetti B, Lange Consiglio A, Recordati C, Bonacina E, Bizzaro D, Cremonesi F. Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells.. Vet Res Commun 2011 Feb;35(2):103-21.
    doi: 10.1007/s11259-010-9457-3pubmed: 21193959google scholar: lookup
  19. Maia L, Landim-Alvarenga FC, Da Mota LS, De Assis Golim M, Laufer-Amorim R, De Vita B, Barberini DJ, Listoni AJ, De Moraes CN, Heckler MC, Amorim RM. Immunophenotypic, immunocytochemistry, ultrastructural, and cytogenetic characterization of mesenchymal stem cells from equine bone marrow.. Microsc Res Tech 2013 Jun;76(6):618-24.
    doi: 10.1002/jemt.22208pubmed: 23533133google scholar: lookup
  20. Iacono E, Brunori L, Pirrone A, Pagliaro PP, Ricci F, Tazzari PL, Merlo B. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse.. Reproduction 2012 Apr;143(4):455-68.
    doi: 10.1530/REP-10-0408pubmed: 22274885google scholar: lookup
  21. Lange-Consiglio A, Corradetti B, Meucci A, Perego R, Bizzaro D, Cremonesi F. Characteristics of equine mesenchymal stem cells derived from amnion and bone marrow: in vitro proliferative and multilineage potential assessment.. Equine Vet J 2013 Nov;45(6):737-44.
    doi: 10.1111/evj.12052pubmed: 23527626google scholar: lookup
  22. Guest DJ, Smith MR, Allen WR. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study.. Equine Vet J 2008 Mar;40(2):178-81.
    doi: 10.2746/042516408X276942pubmed: 18267891google scholar: lookup
  23. Carrade DD, Lame MW, Kent MS, Clark KC, Walker NJ, Borjesson DL. Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells().. Cell Med 2012;4(1):1-11.
    doi: 10.3727/215517912X647217pmc: PMC3495591pubmed: 23152950google scholar: lookup
  24. de Mattos Carvalho A, Alves AL, Golim MA, Moroz A, Hussni CA, de Oliveira PG, Deffune E. Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue.. Vet Immunol Immunopathol 2009 Dec 15;132(2-4):303-6.
    doi: 10.1016/j.vetimm.2009.06.014pubmed: 19647331google scholar: lookup
  25. Arnhold SJ, Goletz I, Klein H, Stumpf G, Beluche LA, Rohde C, Addicks K, Litzke LF. Isolation and characterization of bone marrow-derived equine mesenchymal stem cells.. Am J Vet Res 2007 Oct;68(10):1095-105.
    doi: 10.2460/ajvr.68.10.1095pubmed: 17916017google scholar: lookup
  26. Violini S, Ramelli P, Pisani LF, Gorni C, Mariani P. Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12.. BMC Cell Biol 2009 Apr 22;10:29.
    doi: 10.1186/1471-2121-10-29pmc: PMC2678092pubmed: 19383177google scholar: lookup
  27. Raabe O, Shell K, Würtz A, Reich CM, Wenisch S, Arnhold S. Further insights into the characterization of equine adipose tissue-derived mesenchymal stem cells.. Vet Res Commun 2011 Aug;35(6):355-65.
    doi: 10.1007/s11259-011-9480-zpubmed: 21614641google scholar: lookup
  28. Pascucci L, Curina G, Mercati F, Marini C, Dall'Aglio C, Paternesi B, Ceccarelli P. Flow cytometric characterization of culture expanded multipotent mesenchymal stromal cells (MSCs) from horse adipose tissue: towards the definition of minimal stemness criteria.. Vet Immunol Immunopathol 2011 Dec 15;144(3-4):499-506.
    doi: 10.1016/j.vetimm.2011.07.017pubmed: 21839521google scholar: lookup
  29. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators.. J Cell Biochem 2006 Aug 1;98(5):1076-84.
    doi: 10.1002/jcb.20886pubmed: 16619257google scholar: lookup
  30. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.. Lancet 2004 May 1;363(9419):1439-41.
    pubmed: 15121408doi: 10.1016/S0140-6736(04)16104-7google scholar: lookup
  31. Singh A, Goel SC, Gupta KK, Kumar M, Arun GR, Patil H, Kumaraswamy V, Jha S. The role of stem cells in osteoarthritis: An experimental study in rabbits.. Bone Joint Res 2014;3(2):32-7.
    doi: 10.1302/2046-3758.32.2000187pmc: PMC3926293pubmed: 24526748google scholar: lookup
  32. Schnabel LV, Pezzanite LM, Antczak DF, Felippe MJ, Fortier LA. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.. Stem Cell Res Ther 2014 Jan 24;5(1):13.
    doi: 10.1186/scrt402pmc: PMC4055004pubmed: 24461709google scholar: lookup
  33. Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.. PLoS One 2010 Apr 26;5(4):e10088.
    doi: 10.1371/journal.pone.0010088pmc: PMC2859930pubmed: 20436665google scholar: lookup
  34. Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.. Cell Immunol 2011;270(2):207-16.
    doi: 10.1016/j.cellimm.2011.05.010pubmed: 21700275google scholar: lookup
  35. Liotta F, Angeli R, Cosmi L, Filì L, Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V, Santarlasci V, Consoloni L, Angelotti ML, Romagnani P, Parronchi P, Krampera M, Maggi E, Romagnani S, Annunziato F. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.. Stem Cells 2008 Jan;26(1):279-89.
    doi: 10.1634/stemcells.2007-0454pubmed: 17962701google scholar: lookup
  36. Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, Cohen S, Cohen IR, Zipori D. Toll-like receptors and their ligands control mesenchymal stem cell functions.. Blood 2007 Feb 15;109(4):1422-32.
    doi: 10.1182/blood-2006-06-028704pubmed: 17038530google scholar: lookup
  37. Koch TG, Heerkens T, Thomsen PD, Betts DH. Isolation of mesenchymal stem cells from equine umbilical cord blood.. BMC Biotechnol 2007 May 30;7:26.
    doi: 10.1186/1472-6750-7-26pmc: PMC1904213pubmed: 17537254google scholar: lookup
  38. Koch TG, Thomsen PD, Betts DH. Improved isolation protocol for equine cord blood-derived mesenchymal stromal cells.. Cytotherapy 2009;11(4):443-7.
    doi: 10.1080/14653240902887259pubmed: 19513899google scholar: lookup
  39. Figueiredo MD, Salter CE, Andrietti AL, Vandenplas ML, Hurley DJ, Moore JN. Validation of a reliable set of primer pairs for measuring gene expression by real-time quantitative RT-PCR in equine leukocytes.. Vet Immunol Immunopathol 2009 Sep 15;131(1-2):65-72.
    doi: 10.1016/j.vetimm.2009.03.013pubmed: 19376596google scholar: lookup
  40. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.. Methods 2001 Dec;25(4):402-8.
    doi: 10.1006/meth.2001.1262pubmed: 11846609google scholar: lookup
  41. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.. Clin Chem 2009 Apr;55(4):611-22.
    doi: 10.1373/clinchem.2008.112797pubmed: 19246619google scholar: lookup
  42. Radcliffe CH, Flaminio MJ, Fortier LA. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations.. Stem Cells Dev 2010 Feb;19(2):269-82.
    doi: 10.1089/scd.2009.0091pmc: PMC3138180pubmed: 19604071google scholar: lookup
  43. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.. Genome Biol 2002 Jun 18;3(7):RESEARCH0034.
    pmc: PMC126239pubmed: 12184808doi: 10.1186/gb-2002-3-7-research0034google scholar: lookup
  44. Nailis H, Coenye T, Van Nieuwerburgh F, Deforce D, Nelis HJ. Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR.. BMC Mol Biol 2006 Aug 4;7:25.
    doi: 10.1186/1471-2199-7-25pmc: PMC1557526pubmed: 16889665google scholar: lookup
  45. Kögler G, Sensken S, Wernet P. Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood.. Exp Hematol 2006 Nov;34(11):1589-95.
    doi: 10.1016/j.exphem.2006.07.011pubmed: 17046580google scholar: lookup
  46. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.. Stem Cells 2006 May;24(5):1294-301.
    doi: 10.1634/stemcells.2005-0342pubmed: 16410387google scholar: lookup
  47. Zhang X, Hirai M, Cantero S, Ciubotariu R, Dobrila L, Hirsh A, Igura K, Satoh H, Yokomi I, Nishimura T, Yamaguchi S, Yoshimura K, Rubinstein P, Takahashi TA. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue.. J Cell Biochem 2011 Apr;112(4):1206-18.
    doi: 10.1002/jcb.23042pubmed: 21312238google scholar: lookup
  48. Bieback K, Kern S, Klüter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood.. Stem Cells 2004;22(4):625-34.
    doi: 10.1634/stemcells.22-4-625pubmed: 15277708google scholar: lookup
  49. Schuh EM, Friedman MS, Carrade DD, Li J, Heeke D, Oyserman SM, Galuppo LD, Lara DJ, Walker NJ, Ferraro GL, Owens SD, Borjesson DL. Identification of variables that optimize isolation and culture of multipotent mesenchymal stem cells from equine umbilical-cord blood.. Am J Vet Res 2009 Dec;70(12):1526-35.
    doi: 10.2460/ajvr.70.12.1526pubmed: 19951125google scholar: lookup
  50. De Schauwer C, Meyer E, Cornillie P, De Vliegher S, van de Walle GR, Hoogewijs M, Declercq H, Govaere J, Demeyere K, Cornelissen M, Van Soom A. Optimization of the isolation, culture, and characterization of equine umbilical cord blood mesenchymal stromal cells.. Tissue Eng Part C Methods 2011 Nov;17(11):1061-70.
    doi: 10.1089/ten.tec.2011.0052pubmed: 21870941google scholar: lookup
  51. De Schauwer C, van de Walle GR, Piepers S, Hoogewijs MK, Govaere JL, Meyer E, van Soom A. Successful isolation of equine mesenchymal stromal cells from cryopreserved umbilical cord blood-derived mononuclear cell fractions.. Equine Vet J 2013 Jul;45(4):518-22.
    doi: 10.1111/evj.12003pubmed: 23206252google scholar: lookup
  52. Geng S, Guo Y, Wang Q, Li L, Wang J. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.. Arch Dermatol Res 2013 Jan;305(1):35-47.
    doi: 10.1007/s00403-012-1260-2pubmed: 22740085google scholar: lookup
  53. Haeryfar SM, Hoskin DW. Thy-1: more than a mouse pan-T cell marker.. J Immunol 2004 Sep 15;173(6):3581-8.
    pubmed: 15356100doi: 10.4049/jimmunol.173.6.3581google scholar: lookup
  54. Calloni R, Cordero EA, Henriques JA, Bonatto D. Reviewing and updating the major molecular markers for stem cells.. Stem Cells Dev 2013 May 1;22(9):1455-76.
    doi: 10.1089/scd.2012.0637pmc: PMC3629778pubmed: 23336433google scholar: lookup
  55. Li Q, Qi LJ, Guo ZK, Li H, Zuo HB, Li NN. CD73+ adipose-derived mesenchymal stem cells possess higher potential to differentiate into cardiomyocytes in vitro.. J Mol Histol 2013 Aug;44(4):411-22.
    doi: 10.1007/s10735-013-9492-9pubmed: 23456425google scholar: lookup
  56. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.. Cell Commun Signal 2011 May 14;9:12.
    doi: 10.1186/1478-811X-9-12pmc: PMC3117820pubmed: 21569606google scholar: lookup
  57. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.. Scand J Immunol 2003 Jan;57(1):11-20.
    pubmed: 12542793doi: 10.1046/j.1365-3083.2003.01176.xgoogle scholar: lookup
  58. Pigott JH, Ishihara A, Wellman ML, Russell DS, Bertone AL. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.. Vet Immunol Immunopathol 2013 Nov 15;156(1-2):99-106.
    doi: 10.1016/j.vetimm.2013.09.003pubmed: 24094688google scholar: lookup
  59. Galipeau J. The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?. Cytotherapy 2013 Jan;15(1):2-8.
    doi: 10.1016/j.jcyt.2012.10.002pubmed: 23260081google scholar: lookup
  60. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation.. J Leukoc Biol 2006 Feb;79(2):285-93.
    doi: 10.1189/jlb.0105015pubmed: 16330536google scholar: lookup
  61. Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses.. Stem Cells 2008 Jan;26(1):99-107.
    doi: 10.1634/stemcells.2007-0563pmc: PMC2757778pubmed: 17916800google scholar: lookup
  62. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, Netea MG. Functional consequences of toll-like receptor 4 polymorphisms.. Mol Med 2008 May-Jun;14(5-6):346-52.
    doi: 10.2119/2007-00135.Ferwerdapmc: PMC2215765pubmed: 18231573google scholar: lookup
  63. Lundberg AM, Drexler SK, Monaco C, Williams LM, Sacre SM, Feldmann M, Foxwell BM. Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems.. Blood 2007 Nov 1;110(9):3245-52.
    doi: 10.1182/blood-2007-02-072934pubmed: 17660379google scholar: lookup

Citations

This article has been cited 22 times.
  1. Shin S, Yoon SG, Kim M, Cheon EJ, Jeon Y, Lee HJ, Chung SH. The Effect of Mesenchymal Stem Cells on Dry Eye in Sjogren Syndrome Mouse Model. Int J Mol Sci 2023 Jan 5;24(2).
    doi: 10.3390/ijms24021039pubmed: 36674547google scholar: lookup
  2. Yuan JY, Wang XY, Tong ZY, Dong YC, Zhao JY, Zhang Y, Shang Y. Promising Therapeutic Functions of Bone Marrow Mesenchymal Stem Cells Derived-Exosome in Asthma. Can Respir J 2022;2022:1485719.
    doi: 10.1155/2022/1485719pubmed: 36582191google scholar: lookup
  3. Anna M, Łukasz M, Adam O, Chełmońska-Soyta A. Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life. Sci Rep 2022 Sep 22;12(1):15795.
    doi: 10.1038/s41598-022-17532-1pubmed: 36138050google scholar: lookup
  4. Cequier A, Romero A, Vázquez FJ, Vitoria A, Bernad E, Fuente S, Zaragoza P, Rodellar C, Barrachina L. Equine Mesenchymal Stem Cells Influence the Proliferative Response of Lymphocytes: Effect of Inflammation, Differentiation and MHC-Compatibility. Animals (Basel) 2022 Apr 11;12(8).
    doi: 10.3390/ani12080984pubmed: 35454231google scholar: lookup
  5. Mund SJK, MacPhee DJ, Campbell J, Honaramooz A, Wobeser B, Barber SM. Macroscopic, Histologic, and Immunomodulatory Response of Limb Wounds Following Intravenous Allogeneic Cord Blood-Derived Multipotent Mesenchymal Stromal Cell Therapy in Horses. Cells 2021 Nov 1;10(11).
    doi: 10.3390/cells10112972pubmed: 34831196google scholar: lookup
  6. Chihaby N, Orliaguet M, Le Pottier L, Pers JO, Boisramé S. Treatment of Sjögren's Syndrome with Mesenchymal Stem Cells: A Systematic Review. Int J Mol Sci 2021 Sep 28;22(19).
    doi: 10.3390/ijms221910474pubmed: 34638813google scholar: lookup
  7. Zhu XY, Klomjit N, Conley SM, Ostlie MM, Jordan KL, Lerman A, Lerman LO. Impaired immunomodulatory capacity in adipose tissue-derived mesenchymal stem/stromal cells isolated from obese patients. J Cell Mol Med 2021 Sep;25(18):9051-9059.
    doi: 10.1111/jcmm.16869pubmed: 34418300google scholar: lookup
  8. Salcedo-Jiménez R, Koenig JB, Lee OJ, Gibson TWG, Madan P, Koch TG. Extracorporeal Shock Wave Therapy Enhances the In Vitro Metabolic Activity and Differentiation of Equine Umbilical Cord Blood Mesenchymal Stromal Cells. Front Vet Sci 2020;7:554306.
    doi: 10.3389/fvets.2020.554306pubmed: 33344521google scholar: lookup
  9. Migdał A, Migdał Ł, Oczkowicz M, Okólski A, Chełmońska-Soyta A. Influence of Age and Immunostimulation on the Level of Toll-Like Receptor Gene (TLR3, 4, and 7) Expression in Foals. Animals (Basel) 2020 Oct 26;10(11).
    doi: 10.3390/ani10111966pubmed: 33114637google scholar: lookup
  10. Mocchi M, Dotti S, Bue MD, Villa R, Bari E, Perteghella S, Torre ML, Grolli S. Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?. Cells 2020 Jun 11;9(6).
    doi: 10.3390/cells9061453pubmed: 32545382google scholar: lookup
  11. Mund SJK, Kawamura E, Awang-Junaidi AH, Campbell J, Wobeser B, MacPhee DJ, Honaramooz A, Barber S. Homing and Engraftment of Intravenously Administered Equine Cord Blood-Derived Multipotent Mesenchymal Stromal Cells to Surgically Created Cutaneous Wound in Horses: A Pilot Project. Cells 2020 May 8;9(5).
    doi: 10.3390/cells9051162pubmed: 32397125google scholar: lookup
  12. Al Naem M, Bourebaba L, Kucharczyk K, Röcken M, Marycz K. Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders. Stem Cell Rev Rep 2020 Apr;16(2):301-322.
    doi: 10.1007/s12015-019-09932-0pubmed: 31797146google scholar: lookup
  13. Evaristo-Mendonça F, Sardella-Silva G, Kasai-Brunswick TH, Campos RMP, Domizi P, Santiago MF, de Melo Reis RA, Mendez-Otero R, Ribeiro-Resende VT, Pimentel-Coelho PM. Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists. Stem Cells Int 2019;2019:7692973.
    doi: 10.1155/2019/7692973pubmed: 31531025google scholar: lookup
  14. Hillmann A, Paebst F, Brehm W, Piehler D, Schubert S, Tárnok A, Burk J. A novel direct co-culture assay analyzed by multicolor flow cytometry reveals context- and cell type-specific immunomodulatory effects of equine mesenchymal stromal cells. PLoS One 2019;14(6):e0218949.
    doi: 10.1371/journal.pone.0218949pubmed: 31247035google scholar: lookup
  15. Roberts EL, Dang T, Lepage SIM, Alizadeh AH, Walsh T, Koch TG, Kallos MS. Improved expansion of equine cord blood derived mesenchymal stromal cells by using microcarriers in stirred suspension bioreactors. J Biol Eng 2019;13:25.
    doi: 10.1186/s13036-019-0153-8pubmed: 30949237google scholar: lookup
  16. Chen W, Yu Y, Ma J, Olsen N, Lin J. Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges. Stem Cells Int 2018;2018:4357865.
    doi: 10.1155/2018/4357865pubmed: 30305818google scholar: lookup
  17. Cortés-Araya Y, Amilon K, Rink BE, Black G, Lisowski Z, Donadeu FX, Esteves CL. Comparison of Antibacterial and Immunological Properties of Mesenchymal Stem/Stromal Cells from Equine Bone Marrow, Endometrium, and Adipose Tissue. Stem Cells Dev 2018 Nov 1;27(21):1518-1525.
    doi: 10.1089/scd.2017.0241pubmed: 30044182google scholar: lookup
  18. Desancé M, Contentin R, Bertoni L, Gomez-Leduc T, Branly T, Jacquet S, Betsch JM, Batho A, Legendre F, Audigié F, Galéra P, Demoor M. Chondrogenic Differentiation of Defined Equine Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Use in Cartilage Repair Therapy. Int J Mol Sci 2018 Feb 10;19(2).
    doi: 10.3390/ijms19020537pubmed: 29439436google scholar: lookup
  19. Williams LB, Co C, Koenig JB, Tse C, Lindsay E, Koch TG. Response to Intravenous Allogeneic Equine Cord Blood-Derived Mesenchymal Stromal Cells Administered from Chilled or Frozen State in Serum and Protein-Free Media. Front Vet Sci 2016;3:56.
    doi: 10.3389/fvets.2016.00056pubmed: 27500136google scholar: lookup
  20. Mohammadian M, Boskabady MH, Kashani IR, Jahromi GP, Omidi A, Nejad AK, Khamse S, Sadeghipour HR. Effect of bone marrow derived mesenchymal stem cells on lung pathology and inflammation in ovalbumin-induced asthma in mouse. Iran J Basic Med Sci 2016 Jan;19(1):55-63.
    pubmed: 27096065
  21. Baptistella JC, da Silva CG, Báo SN, Panegossi LC, Cardoso TC, de Carvalho RG, Martins CF. Immunomodulatory-associated gene transcripts to multipotency of bovine amniotic fluid mesenchymal stem cells. Anim Reprod 2024;21(1):e20230155.
    doi: 10.1590/1984-3143-AR2023-0155pubmed: 38628495google scholar: lookup
  22. Roberts EL, Abraham BD, Dang T, Gysel E, Mehrpouyan S, Alizadeh AH, Koch TG, Kallos MS. Computer controlled expansion of equine cord blood mesenchymal stromal cells on microcarriers in 3 L vertical-wheel(®) bioreactors. Front Bioeng Biotechnol 2023;11:1250077.
    doi: 10.3389/fbioe.2023.1250077pubmed: 37929186google scholar: lookup
Subscribe to our newsletter
Join 99,727 horse owners like you who receive our email updates on horse health and nutrition.